MKT Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$431K Sell
1,613
-228
-12% -$53.1K 0.13% 97
2026
Q1
$439K Buy
1,841
+13
+0.7% +$3.03K 0.15% 90
2025
Q4
$373K Sell
1,828
-94
-5% -$18.6K 0.13% 111
2025
Q3
$358K Buy
1,922
+24
+1% +$4.11K 0.13% 109
2025
Q2
$296K Sell
1,898
-22
-1% -$3.38K 0.12% 124
2025
Q1
$289K Buy
1,920
+60
+3% +$9.39K 0.14% 105
2024
Q4
$273K Sell
1,860
-484
-21% -$75K 0.12% 115
2024
Q3
$378K Sell
2,344
-317
-12% -$50.5K 0.18% 90
2024
Q2
$391K Sell
2,661
-111
-4% -$16.5K 0.19% 80
2024
Q1
$416K Sell
2,772
-548
-17% -$87.2K 0.23% 77
2023
Q4
$535K Sell
3,320
-19
-0.6% -$2.91K 0.35% 57
2023
Q3
$518K Buy
3,339
+56
+2% +$9.24K 0.39% 56
2023
Q2
$573K Sell
3,283
-61
-2% -$9.85K 0.4% 49
2023
Q1
$554K Sell
3,344
-46
-1% -$7.43K 0.41% 55
2022
Q4
$593K Buy
3,390
+124
+4% +$21.4K 0.45% 53
2022
Q3
$533K Sell
3,266
-36
-1% -$6.09K 0.46% 52
2022
Q2
$589K Buy
3,302
+36
+1% +$6.41K 0.46% 48
2022
Q1
$579K Buy
3,266
+248
+8% +$42.2K 0.44% 51
2021
Q4
$508K Buy
+3,018
New +$494K 0.4% 52

Other funds holding JNJ

MKT Advisors's JNJ Position: Q2 2026 in Review

MKT Advisors reduced its Johnson & Johnson (JNJ) stake by 12% in Q2 2026, selling an estimated $53.1K and leaving 1,613 shares worth $431K. The position accounts for 0.13% of the portfolio, ranked #97.

MKT Advisors first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. The position peaked at $593K in Q4 2022. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • MKT Advisors held 1,613 shares of Johnson & Johnson worth $431K as of Q2 2026.
  • MKT Advisors sold 228 Johnson & Johnson shares in Q2 2026, an estimated $53.1K.
  • Johnson & Johnson made up 0.13% of MKT Advisors's portfolio in Q2 2026, its #97 holding.
  • MKT Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • MKT Advisors's Johnson & Johnson position peaked at $593K in Q4 2022.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on MKT Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.